DxAngels

Syndicate San Francisco, United States · Founded 2024

DxAngels is an investment syndicate of Doximity alumni, doctors, and health tech leaders that invests in early-stage digital health startups. They focus on companies that have moved beyond initial product-market fit and are looking to scale, offering capital and expertise to help founders grow their businesses.

About DxAngels

DxAngels is an angel network or syndicate with a website but no LinkedIn or Crunchbase presence in the source data and no disclosed thesis, stage, sector, or check size. The name strongly suggests a diagnostics-focused angel network, with Dx being a common abbreviation for diagnostics in healthcare, and the Angels suffix indicating a syndicate of individual investors rather than a fund. For healthcare AI founders, DxAngels is most plausibly relevant if you are building diagnostic AI, including pathology, radiology, in vitro diagnostics with computational components, or related diagnostic decision support platforms. The angel network model means individual member checks typically range from $25K to $250K, with aggregate round participation potentially reaching $250K to $1.5M depending on member interest and round size. Founders outside the diagnostics vertical are unlikely to find a fit, and the network is unlikely to play a thesis-leading role; rather, it can supplement a primary lead investor with diagnostic-savvy angel capital and informal advisory value. Founders building therapeutics, care delivery, or non-diagnostic healthcare AI should look elsewhere. The firm’s value-add is most credible around diagnostic clinical and commercial expertise contributed by individual angel members, which can be substantial when members include practicing pathologists, radiologists, or diagnostic industry executives. Entry path is the website application or direct outreach to whoever is listed as the network operator. Founders should come with clear diagnostic clinical evidence, regulatory pathway, and a credible commercial plan oriented toward labs, hospitals, or payers. Treat DxAngels as an angel-round supplement rather than a primary fundraising target.

Founder reviews

No founder reviews yet. Raised from this fund? Share your experience with other founders.

Other portfolio companies

Companies in DxAngels's portfolio not currently in our directory.

  • Nue Life Health
  • Wellnite
  • Oto Health
  • Cardiosense
  • RefAssured
  • Orchestrated Intelligence
  • Equi
  • Viable
  • Objective
  • Sellscale
  • Turboprop AI
  • Andwise

Team

Ahmed Belal
Managing Partner
LinkedIn
Mujtaba (MJ) Badat
Managing Partner
LinkedIn
Dr. Peter Alperin
Venture Partner
LinkedIn

Pitch / review this investor

Have you raised from DxAngels? Founders only — share your honest experience (anonymous OK, moderated before publishing).

Share your experience
Last updated 2026-05-06. Sourced from this fund's published materials.
AI Tool Finder
AI-powered search. Results may not be comprehensive.